Hand-held Glucose Meter Market By Product (Standard Glucose Meters, Smart Glucose Meters, Continuous Glucose Monitors) , By End User (Hospitals and Clinics, Homecare, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
The hand-held glucose meter market was valued at $1.2 billion in 2023, and is projected to reach $2.0 billion by 2033, growing at a CAGR of 5.3% from 2024 to 2033.
A hand-held glucose meter is a compact, portable medical device designed to measure and monitor blood glucose levels. It serves as an essential tool for individuals with diabetes, allowing them to track their blood sugar levels accurately and conveniently from home or on the go. The device works by analyzing a small drop of blood, usually obtained through a finger prick, which is placed on a disposable test strip. The glucose meter then provides a digital readout of the blood glucose concentration within seconds.
The growth of the global hand-held glucose meter market is driven by alarming rise in prevalence of diabetes and surge in demand for reliable glucose monitoring devices. The IDF Diabetes Atlas (2021) reports that approximately 540 million individuals were suffering from diabetes worldwide. This number is estimated to rise to 643 million by 2030 and 783 million by 2045. In addition, increase in awareness of self-monitoring for diabetes management has fostered the demand for user-friendly and accurate handheld glucose meters, thus strengthening the market growth. Furthermore, surge in geriatric population significantly contributes toward the growth of the global market. This is attributed to the fact that as people age, their bodies experience a natural decline in insulin production and sensitivity, leading to higher blood glucose levels and an increased risk of developing type 2 diabetes. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050. Moreover, shift toward preventive healthcare that encourages more people to monitor their health conditions regularly augments the adoption of personal glucose meters. However, accuracy and calibration concerns associated with hand-held glucose meters hamper the market growth. In addition, lack of diabetes education and economic constraints act as the key deterrent factors of the global market. On the contrary, continuous improvements in sensor technology, data connectivity, and digital health integration have made glucose meters more accurate, easier to use, and compatible with health apps, enhancing their appeal and usability. Such developments are expected to offer lucrative opportunities for the expansion of the global market during the forecast period.
The global hand-held glucose meter industry is segmented into product, end user, and region. On the basis of product, the market is classified into standard glucose meters, smart glucose meters, and continuous glucose monitors. Depending on end user, it is divided into hospitals & clinics, homecare, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of product, the smart glucose meters segment is expected to dominated the market from 2024 to 2033.
Depending on end user, the hospitals & clinics segment is anticipated to exhibit the highest growth during the forecast period.
By region, North America held the largest market share in terms of revenue in 2023, and is projected to dominate the market throughout the forecast period.
Competition Analysis
Competitive analysis and profiles of the major players in the global hand-held glucose meter market include F. Hoffmann La Roche, Abbott Laboratories, Johnson & Johnson Company, DexCom, Inc., Medtronic Plc, Bayer AG, Ascensia Diabetes Care Holdings AG, Terumo Corporation, Nova Biomedical Corporation, and Ypsomed Holding AG. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.
Key Market Segments
By Product
Standard Glucose Meters
Smart Glucose Meters
Continuous Glucose Monitors
By End User
Hospitals and Clinics
Homecare
Others
By Region
North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
Key Market Players
F. Hoffmann La Roche
Abbott Laboratories
Johnson & Johnson Company
DexCom, Inc.
Medtronic plc
Bayer AG
Ascensia Diabetes Care Holdings AG
Terumo Corporation
Nova Biomedical Corporation
Ypsomed Holding AG
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: HAND-HELD GLUCOSE METER MARKET, BY PRODUCT
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Product
- 4.2. Standard Glucose Meters
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Smart Glucose Meters
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. Continuous Glucose Monitors
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
- CHAPTER 5: HAND-HELD GLUCOSE METER MARKET, BY END USER
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By End User
- 5.2. Hospitals And Clinics
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Homecare
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Others
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
- CHAPTER 6: HAND-HELD GLUCOSE METER MARKET, BY REGION
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Region
- 6.2. North America
- 6.2.1. Key Market Trends and Opportunities
- 6.2.2. Market Size and Forecast, By Product
- 6.2.3. Market Size and Forecast, By End User
- 6.2.4. Market Size and Forecast, By Country
- 6.2.5. U.S. Hand-held Glucose Meter Market
- 6.2.5.1. Market Size and Forecast, By Product
- 6.2.5.2. Market Size and Forecast, By End User
- 6.2.6. Canada Hand-held Glucose Meter Market
- 6.2.6.1. Market Size and Forecast, By Product
- 6.2.6.2. Market Size and Forecast, By End User
- 6.2.7. Mexico Hand-held Glucose Meter Market
- 6.2.7.1. Market Size and Forecast, By Product
- 6.2.7.2. Market Size and Forecast, By End User
- 6.3. Europe
- 6.3.1. Key Market Trends and Opportunities
- 6.3.2. Market Size and Forecast, By Product
- 6.3.3. Market Size and Forecast, By End User
- 6.3.4. Market Size and Forecast, By Country
- 6.3.5. France Hand-held Glucose Meter Market
- 6.3.5.1. Market Size and Forecast, By Product
- 6.3.5.2. Market Size and Forecast, By End User
- 6.3.6. Germany Hand-held Glucose Meter Market
- 6.3.6.1. Market Size and Forecast, By Product
- 6.3.6.2. Market Size and Forecast, By End User
- 6.3.7. Italy Hand-held Glucose Meter Market
- 6.3.7.1. Market Size and Forecast, By Product
- 6.3.7.2. Market Size and Forecast, By End User
- 6.3.8. Spain Hand-held Glucose Meter Market
- 6.3.8.1. Market Size and Forecast, By Product
- 6.3.8.2. Market Size and Forecast, By End User
- 6.3.9. UK Hand-held Glucose Meter Market
- 6.3.9.1. Market Size and Forecast, By Product
- 6.3.9.2. Market Size and Forecast, By End User
- 6.3.10. Rest Of Europe Hand-held Glucose Meter Market
- 6.3.10.1. Market Size and Forecast, By Product
- 6.3.10.2. Market Size and Forecast, By End User
- 6.4. Asia-Pacific
- 6.4.1. Key Market Trends and Opportunities
- 6.4.2. Market Size and Forecast, By Product
- 6.4.3. Market Size and Forecast, By End User
- 6.4.4. Market Size and Forecast, By Country
- 6.4.5. China Hand-held Glucose Meter Market
- 6.4.5.1. Market Size and Forecast, By Product
- 6.4.5.2. Market Size and Forecast, By End User
- 6.4.6. Japan Hand-held Glucose Meter Market
- 6.4.6.1. Market Size and Forecast, By Product
- 6.4.6.2. Market Size and Forecast, By End User
- 6.4.7. India Hand-held Glucose Meter Market
- 6.4.7.1. Market Size and Forecast, By Product
- 6.4.7.2. Market Size and Forecast, By End User
- 6.4.8. South Korea Hand-held Glucose Meter Market
- 6.4.8.1. Market Size and Forecast, By Product
- 6.4.8.2. Market Size and Forecast, By End User
- 6.4.9. Australia Hand-held Glucose Meter Market
- 6.4.9.1. Market Size and Forecast, By Product
- 6.4.9.2. Market Size and Forecast, By End User
- 6.4.10. Rest of Asia-Pacific Hand-held Glucose Meter Market
- 6.4.10.1. Market Size and Forecast, By Product
- 6.4.10.2. Market Size and Forecast, By End User
- 6.5. LAMEA
- 6.5.1. Key Market Trends and Opportunities
- 6.5.2. Market Size and Forecast, By Product
- 6.5.3. Market Size and Forecast, By End User
- 6.5.4. Market Size and Forecast, By Country
- 6.5.5. Brazil Hand-held Glucose Meter Market
- 6.5.5.1. Market Size and Forecast, By Product
- 6.5.5.2. Market Size and Forecast, By End User
- 6.5.6. South Africa Hand-held Glucose Meter Market
- 6.5.6.1. Market Size and Forecast, By Product
- 6.5.6.2. Market Size and Forecast, By End User
- 6.5.7. Saudi Arabia Hand-held Glucose Meter Market
- 6.5.7.1. Market Size and Forecast, By Product
- 6.5.7.2. Market Size and Forecast, By End User
- 6.5.8. Rest of LAMEA Hand-held Glucose Meter Market
- 6.5.8.1. Market Size and Forecast, By Product
- 6.5.8.2. Market Size and Forecast, By End User
- CHAPTER 7: COMPETITIVE LANDSCAPE
- 7.1. Introduction
- 7.2. Top Winning Strategies
- 7.3. Product Mapping Of Top 10 Player
- 7.4. Competitive Dashboard
- 7.5. Competitive Heatmap
- 7.6. Top Player Positioning, 2023
- CHAPTER 8: COMPANY PROFILES
- 8.1. F. Hoffmann La Roche
- 8.1.1. Company Overview
- 8.1.2. Key Executives
- 8.1.3. Company Snapshot
- 8.1.4. Operating Business Segments
- 8.1.5. Product Portfolio
- 8.1.6. Business Performance
- 8.1.7. Key Strategic Moves and Developments
- 8.2. Abbott Laboratories
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Operating Business Segments
- 8.2.5. Product Portfolio
- 8.2.6. Business Performance
- 8.2.7. Key Strategic Moves and Developments
- 8.3. Johnson And Johnson Company
- 8.3.1. Company Overview
- 8.3.2. Key Executives
- 8.3.3. Company Snapshot
- 8.3.4. Operating Business Segments
- 8.3.5. Product Portfolio
- 8.3.6. Business Performance
- 8.3.7. Key Strategic Moves and Developments
- 8.4. DexCom, Inc.
- 8.4.1. Company Overview
- 8.4.2. Key Executives
- 8.4.3. Company Snapshot
- 8.4.4. Operating Business Segments
- 8.4.5. Product Portfolio
- 8.4.6. Business Performance
- 8.4.7. Key Strategic Moves and Developments
- 8.5. Medtronic Plc
- 8.5.1. Company Overview
- 8.5.2. Key Executives
- 8.5.3. Company Snapshot
- 8.5.4. Operating Business Segments
- 8.5.5. Product Portfolio
- 8.5.6. Business Performance
- 8.5.7. Key Strategic Moves and Developments
- 8.6. Bayer AG
- 8.6.1. Company Overview
- 8.6.2. Key Executives
- 8.6.3. Company Snapshot
- 8.6.4. Operating Business Segments
- 8.6.5. Product Portfolio
- 8.6.6. Business Performance
- 8.6.7. Key Strategic Moves and Developments
- 8.7. Ascensia Diabetes Care Holdings AG
- 8.7.1. Company Overview
- 8.7.2. Key Executives
- 8.7.3. Company Snapshot
- 8.7.4. Operating Business Segments
- 8.7.5. Product Portfolio
- 8.7.6. Business Performance
- 8.7.7. Key Strategic Moves and Developments
- 8.8. Terumo Corporation
- 8.8.1. Company Overview
- 8.8.2. Key Executives
- 8.8.3. Company Snapshot
- 8.8.4. Operating Business Segments
- 8.8.5. Product Portfolio
- 8.8.6. Business Performance
- 8.8.7. Key Strategic Moves and Developments
- 8.9. Nova Biomedical Corporation
- 8.9.1. Company Overview
- 8.9.2. Key Executives
- 8.9.3. Company Snapshot
- 8.9.4. Operating Business Segments
- 8.9.5. Product Portfolio
- 8.9.6. Business Performance
- 8.9.7. Key Strategic Moves and Developments
- 8.10. Ypsomed Holding AG
- 8.10.1. Company Overview
- 8.10.2. Key Executives
- 8.10.3. Company Snapshot
- 8.10.4. Operating Business Segments
- 8.10.5. Product Portfolio
- 8.10.6. Business Performance
- 8.10.7. Key Strategic Moves and Developments
- LIST OF TABLES
- TABLE 1. GLOBAL HAND-HELD GLUCOSE METER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 2. HAND-HELD GLUCOSE METER MARKET FOR STANDARD GLUCOSE METERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 3. HAND-HELD GLUCOSE METER MARKET FOR SMART GLUCOSE METERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 4. HAND-HELD GLUCOSE METER MARKET FOR CONTINUOUS GLUCOSE MONITORS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 5. GLOBAL HAND-HELD GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 6. HAND-HELD GLUCOSE METER MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 7. HAND-HELD GLUCOSE METER MARKET FOR HOMECARE, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 8. HAND-HELD GLUCOSE METER MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 9. HAND-HELD GLUCOSE METER MARKET, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 10. NORTH AMERICA HAND-HELD GLUCOSE METER MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 11. NORTH AMERICA HAND-HELD GLUCOSE METER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 12. NORTH AMERICA HAND-HELD GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 13. U.S. HAND-HELD GLUCOSE METER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 14. U.S. HAND-HELD GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 15. CANADA HAND-HELD GLUCOSE METER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 16. CANADA HAND-HELD GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 17. MEXICO HAND-HELD GLUCOSE METER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 18. MEXICO HAND-HELD GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 19. EUROPE HAND-HELD GLUCOSE METER MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 20. EUROPE HAND-HELD GLUCOSE METER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 21. EUROPE HAND-HELD GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 22. FRANCE HAND-HELD GLUCOSE METER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 23. FRANCE HAND-HELD GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 24. GERMANY HAND-HELD GLUCOSE METER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 25. GERMANY HAND-HELD GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 26. ITALY HAND-HELD GLUCOSE METER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 27. ITALY HAND-HELD GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 28. SPAIN HAND-HELD GLUCOSE METER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 29. SPAIN HAND-HELD GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 30. UK HAND-HELD GLUCOSE METER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 31. UK HAND-HELD GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 32. REST OF EUROPE HAND-HELD GLUCOSE METER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 33. REST OF EUROPE HAND-HELD GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 34. ASIA-PACIFIC HAND-HELD GLUCOSE METER MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 35. ASIA-PACIFIC HAND-HELD GLUCOSE METER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 36. ASIA-PACIFIC HAND-HELD GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 37. CHINA HAND-HELD GLUCOSE METER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 38. CHINA HAND-HELD GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 39. JAPAN HAND-HELD GLUCOSE METER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 40. JAPAN HAND-HELD GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 41. INDIA HAND-HELD GLUCOSE METER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 42. INDIA HAND-HELD GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 43. SOUTH KOREA HAND-HELD GLUCOSE METER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 44. SOUTH KOREA HAND-HELD GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 45. AUSTRALIA HAND-HELD GLUCOSE METER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 46. AUSTRALIA HAND-HELD GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 47. REST OF ASIA-PACIFIC HAND-HELD GLUCOSE METER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 48. REST OF ASIA-PACIFIC HAND-HELD GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 49. LAMEA HAND-HELD GLUCOSE METER MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 50. LAMEA HAND-HELD GLUCOSE METER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 51. LAMEA HAND-HELD GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 52. BRAZIL HAND-HELD GLUCOSE METER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 53. BRAZIL HAND-HELD GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 54. SOUTH AFRICA HAND-HELD GLUCOSE METER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 55. SOUTH AFRICA HAND-HELD GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 56. SAUDI ARABIA HAND-HELD GLUCOSE METER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 57. SAUDI ARABIA HAND-HELD GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 58. REST OF LAMEA HAND-HELD GLUCOSE METER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 59. REST OF LAMEA HAND-HELD GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 60. F. HOFFMANN LA ROCHE: KEY EXECUTIVES
- TABLE 61. F. HOFFMANN LA ROCHE: COMPANY SNAPSHOT
- TABLE 62. F. HOFFMANN LA ROCHE: OPERATING SEGMENTS
- TABLE 63. F. HOFFMANN LA ROCHE: PRODUCT PORTFOLIO
- TABLE 64. F. HOFFMANN LA ROCHE: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 65. ABBOTT LABORATORIES: KEY EXECUTIVES
- TABLE 66. ABBOTT LABORATORIES: COMPANY SNAPSHOT
- TABLE 67. ABBOTT LABORATORIES: OPERATING SEGMENTS
- TABLE 68. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
- TABLE 69. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 70. JOHNSON AND JOHNSON COMPANY: KEY EXECUTIVES
- TABLE 71. JOHNSON AND JOHNSON COMPANY: COMPANY SNAPSHOT
- TABLE 72. JOHNSON AND JOHNSON COMPANY: OPERATING SEGMENTS
- TABLE 73. JOHNSON AND JOHNSON COMPANY: PRODUCT PORTFOLIO
- TABLE 74. JOHNSON AND JOHNSON COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 75. DEXCOM, INC.: KEY EXECUTIVES
- TABLE 76. DEXCOM, INC.: COMPANY SNAPSHOT
- TABLE 77. DEXCOM, INC.: OPERATING SEGMENTS
- TABLE 78. DEXCOM, INC.: PRODUCT PORTFOLIO
- TABLE 79. DEXCOM, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 80. MEDTRONIC PLC: KEY EXECUTIVES
- TABLE 81. MEDTRONIC PLC: COMPANY SNAPSHOT
- TABLE 82. MEDTRONIC PLC: OPERATING SEGMENTS
- TABLE 83. MEDTRONIC PLC: PRODUCT PORTFOLIO
- TABLE 84. MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 85. BAYER AG: KEY EXECUTIVES
- TABLE 86. BAYER AG: COMPANY SNAPSHOT
- TABLE 87. BAYER AG: OPERATING SEGMENTS
- TABLE 88. BAYER AG: PRODUCT PORTFOLIO
- TABLE 89. BAYER AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 90. ASCENSIA DIABETES CARE HOLDINGS AG: KEY EXECUTIVES
- TABLE 91. ASCENSIA DIABETES CARE HOLDINGS AG: COMPANY SNAPSHOT
- TABLE 92. ASCENSIA DIABETES CARE HOLDINGS AG: OPERATING SEGMENTS
- TABLE 93. ASCENSIA DIABETES CARE HOLDINGS AG: PRODUCT PORTFOLIO
- TABLE 94. ASCENSIA DIABETES CARE HOLDINGS AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 95. TERUMO CORPORATION: KEY EXECUTIVES
- TABLE 96. TERUMO CORPORATION: COMPANY SNAPSHOT
- TABLE 97. TERUMO CORPORATION: OPERATING SEGMENTS
- TABLE 98. TERUMO CORPORATION: PRODUCT PORTFOLIO
- TABLE 99. TERUMO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 100. NOVA BIOMEDICAL CORPORATION: KEY EXECUTIVES
- TABLE 101. NOVA BIOMEDICAL CORPORATION: COMPANY SNAPSHOT
- TABLE 102. NOVA BIOMEDICAL CORPORATION: OPERATING SEGMENTS
- TABLE 103. NOVA BIOMEDICAL CORPORATION: PRODUCT PORTFOLIO
- TABLE 104. NOVA BIOMEDICAL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 105. YPSOMED HOLDING AG: KEY EXECUTIVES
- TABLE 106. YPSOMED HOLDING AG: COMPANY SNAPSHOT
- TABLE 107. YPSOMED HOLDING AG: OPERATING SEGMENTS
- TABLE 108. YPSOMED HOLDING AG: PRODUCT PORTFOLIO
- TABLE 109. YPSOMED HOLDING AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
- LIST OF FIGURES
- FIGURE 1. GLOBAL HAND-HELD GLUCOSE METER MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF HAND-HELD GLUCOSE METER MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN HAND-HELD GLUCOSE METER MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALHAND-HELD GLUCOSE METER MARKET
- FIGURE 10. GLOBAL HAND-HELD GLUCOSE METER MARKET SEGMENTATION, BY PRODUCT
- FIGURE 11. HAND-HELD GLUCOSE METER MARKET FOR STANDARD GLUCOSE METERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 12. HAND-HELD GLUCOSE METER MARKET FOR SMART GLUCOSE METERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. HAND-HELD GLUCOSE METER MARKET FOR CONTINUOUS GLUCOSE MONITORS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 14. GLOBAL HAND-HELD GLUCOSE METER MARKET SEGMENTATION, BY END USER
- FIGURE 15. HAND-HELD GLUCOSE METER MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 16. HAND-HELD GLUCOSE METER MARKET FOR HOMECARE, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 17. HAND-HELD GLUCOSE METER MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 18. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 19. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 20. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 21. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 22. COMPETITIVE DASHBOARD
- FIGURE 23. COMPETITIVE HEATMAP: HAND-HELD GLUCOSE METER MARKET
- FIGURE 24. TOP PLAYER POSITIONING, 2023
- FIGURE 25. F. HOFFMANN LA ROCHE: NET SALES, 2021-2023 ($BILLION)
- FIGURE 26. F. HOFFMANN LA ROCHE: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 27. F. HOFFMANN LA ROCHE: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 28. ABBOTT LABORATORIES: NET SALES, 2021-2023 ($BILLION)
- FIGURE 29. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 30. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 31. JOHNSON AND JOHNSON COMPANY: NET SALES, 2021-2023 ($BILLION)
- FIGURE 32. JOHNSON AND JOHNSON COMPANY: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 33. JOHNSON AND JOHNSON COMPANY: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 34. DEXCOM, INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 35. DEXCOM, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 36. DEXCOM, INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 37. MEDTRONIC PLC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 38. MEDTRONIC PLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 39. MEDTRONIC PLC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 40. BAYER AG: NET SALES, 2021-2023 ($BILLION)
- FIGURE 41. BAYER AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 42. BAYER AG: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 43. ASCENSIA DIABETES CARE HOLDINGS AG: NET SALES, 2021-2023 ($BILLION)
- FIGURE 44. ASCENSIA DIABETES CARE HOLDINGS AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 45. ASCENSIA DIABETES CARE HOLDINGS AG: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 46. TERUMO CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 47. TERUMO CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 48. TERUMO CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 49. NOVA BIOMEDICAL CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 50. NOVA BIOMEDICAL CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 51. NOVA BIOMEDICAL CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 52. YPSOMED HOLDING AG: NET SALES, 2021-2023 ($BILLION)
- FIGURE 53. YPSOMED HOLDING AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 54. YPSOMED HOLDING AG: REVENUE SHARE, BY REGION, 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook